RP Management, LLC - Q2 2016 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2016
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOHAVEN PHARMACTL HLDG CO L16Q3 202277.6%
EPIZYME INC11Q2 202244.1%
EPIZYME INC11Q2 202213.9%
VIRACTA THERAPEUTICS INC11Q3 20235.7%
CYTOKINETICS INC10Q1 20217.6%
SUNESIS PHARMACEUTICALS INC9Q4 20200.1%
IMMUNOMEDICS INC8Q3 202055.7%
BIOCRYST PHARMACEUTICALS INC8Q3 202352.0%
BIOHAVEN LTD4Q3 202373.7%

View RP Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
RP Management, LLC Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CYPRESS BIOSCIENCE INCDecember 23, 20103,815,0009.9%

View RP Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-08
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
42022-08-16
13F-HR2022-08-10
42022-05-19

View RP Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export RP Management, LLC's holdings

CSVXLS